Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Placebo-Controlled Crossover Study to Determine the Effects of Methylphenidate on Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

NCT00223561 is registered in ClinicalTrials.gov with Utrecht Institute for Pharmaceutical Sciences as lead sponsor.

NCT NCT00223561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00223561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Placebo-Controlled Crossover Study to Determine the Effects of Methylphenidate on Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder
Lead sponsor
Utrecht Institute for Pharmaceutical Sciences
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2003
Completion date
February 28, 2006
Enrollment
18
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd